Image source: The Motley Fool. IRIDEX Corporation (NASDAQ:IRIX) reported that stronger U.S. and international sales in both glaucoma and retina products drove double-digit top-line growth in the ...
Gross margin declined to 37% in Q4 from 44% in the prior year, attributed to higher manufacturing costs, tariff impacts, and reduced capitalization of overhead as inventories tightened. Full-year ...
IRIDEX Corporation beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.02. Jordan: Thank you for standing by. My name is Jordan, and I will be your conference operator today. At ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results